Newlink Genetics Corporation
Records under this name other than the patents Newlink Genetics Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Back to Newlink Genetics Corporation
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,090,643 | Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,732,035 | Salts and prodrugs of 1-methyl-D-tryptophan Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,207,990 | Salts and prodrugs of 1-methyl-D-tryptophan Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,800,780 | TDO2 Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 11,485,705 | Salts and prodrugs of 1-methyl-d-tryptophan Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,827,639 | TDO2 and IDO1 Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 7,998,486 | Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes Formerly held Lapsed on the fee record Ended Aug 16, 2023 · From the USPTO record | Lapsed on the fee record | Ended Aug 16, 2023 | From the USPTO record |
| US 8,916,169 | Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes Formerly held Lapsed on the fee record Ended Dec 23, 2022 · From the USPTO record | Lapsed on the fee record | Ended Dec 23, 2022 | From the USPTO record |
| US 10,047,066 | IDO inhibitors Lapsed on the fee record Ended Aug 14, 2022 · From the USPTO record | Lapsed on the fee record | Ended Aug 14, 2022 | From the USPTO record |
| US 8,748,469 | IDO inhibitors Lapsed on the fee record Ended Jun 10, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jun 10, 2022 | From the USPTO record |